Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

Cited by (336)

Items 201–300 of 336

1. Insulin Resistance in the Polycystic Ovary Syndrome
   Carol-Beth S. Book, Andrea Elizabeth Dunaif · 1996 · Springer eBooks
2. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome
   Juan José Espinós, Rosa Corcoy, Joaquím Calaf · 2009 · Gynecological Endocrinology
3. Endocrinology of Pregnancy
   JAMES H. LIU · 2009 · Elsevier eBooks
4. The polycystic ovary syndrome: the first 150 years of study
   Eli Y. Adashi, David Cibula, Matthew Peterson, Ricardo Azziz · 2022 · F&S Reports
5. Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial
   Shrita M. Patel, Nayyar Iqbal, Shailja Kaul, Sarah J. Ratcliffe, Michael Roehrhoff Rickels, Muredach P. Reilly, Theresa M. Scattergood, Arpita Basu, Carissa S. Fuller, Anne Rentoumis Cappola · 2010 · Fertility and Sterility
6. Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
   Hyejin Lee, Jee Young Oh, Yeon‐Ah Sung, Hyewon Chung · 2013 · Yonsei Medical Journal
7. Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
   Alexandre Connolly, Samuel Leblanc, Jean‐Patrice Baillargeon · 2018 · International Journal of Endocrinology
8. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome
   Toru Takeuchi, Osamu Tsutsumi, Yuji Taketani · 2008 · Gynecological Endocrinology
9. PATHOPHYSIOLOGY, GENETICS, AND TREATMENT OF HYPERANDROGENISM
   Walter L. Miller · 1997 · Pediatric Clinics of North America
10. Cysteine–Cysteine Motif Chemokine Receptor 5 Expression in Letrozole-Induced Polycystic Ovary Syndrome Mice
    Kok‐Min Seow, Pin-Shiou Liu, Kuo-Hu Chen, Chien‐Wei Chen, Luen-Kui Chen, Chi-Hong Ho, Jiann‐Loung Hwang, Peng‐Hui Wang, Chi‐Chang Juan · 2021 · International Journal of Molecular Sciences
11. Diagnosis and Treatment of Polycystic Ovarian Syndrome and Insulin Resistance
    Amy Fleischman, Joan Mansfield · 2005 · Pediatric Annals
12. Excess androgen production in subcutaneous adipose tissue of women with polycystic ovarian syndrome is not related to insulin or LH
    Saad A.K.S. Amer, Nadia G Alzanati, Avril Warren, Rebecca Tarbox, Raheela N. Khan · 2019 · Journal of Endocrinology
13. Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
    Karen E Elkind-Hirsch · 2006 · Treatments in Endocrinology
14. Use of Metformin for Ovulation Induction in Women Who Have Polycystic Ovary Syndrome With or Without Evidence of Insulin Resistance
    Kimberly E. Liu, IVANNA V. TATARYN, Margaret A. Sagle · 2006 · Journal of Obstetrics and Gynaecology Canada
15. Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
    Tabatha Petrillo, Elisa Semprini, Veronica Tomatis, Melania Arnesano, Fedora Ambrosetti, Christian Battipaglia, Alessandra Sponzilli, Francesco Ricciardiello, Andrea Ricardo Genazzani, Alessandro David Genazzani · 2022 · Biomedicines
16. Chronic anovulation and the polycystic ovary syndrome
    NATHAN G. KASE · 2013 · Cambridge University Press eBooks
17. Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness
    Erika Lystedt, Hanna Westergren, Jan Brynhildsen, Lotta Lindh‐Åstrand, Johanna Gustavsson, Fredrik Hans Nyström, Mats L. Hammar, Peter Strålfors · 2005 · European Journal of Endocrinology
18. Genetic analysis of candidate genes for the polycystic ovary syndrome
    Margrit Urbanek, Richard S. Spielman · 2002 · Current Opinion in Endocrinology & Diabetes
19. Key signalling pathways underlying the aetiology of polycystic ovary syndrome
    Kirsty A. Walters, Alba Moreno-Asso, Nigel K. Stepto, Michaël W. Pankhurst, Valentina Rodriguez Paris, Raymond Joseph Rodgers · 2022 · Journal of Endocrinology
20. Recent advances in the treatment of polycystic ovary syndrome
    Bülent Okan Yıldız · 2004 · Expert Opinion on Investigational Drugs
21. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome
    Eftihios Trakakis, George Basios, Μelpomeni Peppa, George Simeonidis, George Labos, Maria G. Creatsa, Maria Misailidou, Eleni I. Boutati, Vassilios Vaggopoulos, Περικλής Παναγόπουλος et al. · 2012 · Gynecological Endocrinology
22. Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
    Preethi Srikanthan, Stanley G. Korenman, Susan Stanik Davis · 2006 · Endocrinology and Metabolism Clinics of North America
23. Improved Responsiveness of PCOS Patients to Clomiphene After CYP17a Inhibitor
    Hassan Ali Hassan, D. El-Gezeiry, Tamer M. Nafaa, Iman Baghdady · 2001 · Journal of Assisted Reproduction and Genetics
24. Mutation analysis of theWNT-4gene in patients with polycystic ovary syndrome
    Patricia Canto, Daniela Söderlund, Sebastián Carranza‐Lira, Juan Pablo Méndez · 2006 · Gynecological Endocrinology
25. Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
    Jean‐Patrice Baillargeon, Maria J. Iuorno, John E. Nestler · 2002 · Current Opinion in Endocrinology & Diabetes
26. Adipocyte insulin action following ovulation in polycystic ovarian syndrome
    Philippa J. Marsden, Alison P. Murdoch, Roy Taylor · 1999 · Human Reproduction
27. Pioglitazone Therapy Increases Insulin-Stimulated Release of d - Chiro -Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome
    Anshu Gupta, Daniela J. Jakubowicz, John E. Nestler · 2016 · Metabolic Syndrome and Related Disorders
28. Insulin: does it induce follicular arrest in the rat ovary?
    Naci Kemal Kuşçu, Faik Mümtaz Koyuncu, Kemal Özbilgin, S Inan, Mehmet İbrahim Tuğlu, Öznur Karaer · 2002 · Gynecological Endocrinology
29. Molecular Mechanisms of Insulin Resistance in the Polycystic Ovary Syndrome
    Theodore P. Ciaraldi · 2007 · Humana Press eBooks
30. Prenatal Testosterone Exposure Disrupts Insulin Secretion and Promotes Insulin Resistance
    Carrasco, Albert, Recabarren, Mónica P., Rojas-García, Pedro P., Gutiérrez, Mario, Morales, Karina, Sir-Petermann, Teresa, Recabarren, Sergio E. · 2020 · Scientific Reports
31. The 6th Annual World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2009 · Diabetes Care
32. Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency
    Selma Feldman Witchel, Silva A Arslanian · 1999 · Clinical Endocrinology
33. Insulin Resistance Effects on Sex Hormones and Ovulation in the Polycystic Ovary Syndrome
    John E. Nestler · 1999 · Humana Press eBooks
34. In vivo regulation of the steroidogenic activity of rat luteal cells by insulin
    Paula Stein, Leonardo E. Bussmann, Marta Tesone · 1995 · The Journal of Steroid Biochemistry and Molecular Biology
35. The Genetic Basis of the Polycystic Ovary Syndrome
    Mark O. Goodarzi · 2007 · Humana Press eBooks
36. Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study
    Jie Cai, Jiang Yue, Nan Lu, Shengxian Li, Jun Zheng, Rong Huang, Yihong Jiang, Chang Shan, Wei Liu, Jing Ma et al. · 2024 · Journal of Clinical Medicine
37. SNP analysis of follistatin gene associated with polycystic ovarian syndrome
    Sivakumari Kanakarajan · 2010 · Advances and Applications in Bioinformatics and Chemistry
38. The interplay between oxidative stress, zinc, and metabolic dysfunction in polycystic ovarian syndrome
    Olivia G. Camp, Daniel N. Moussa, Richard C. Hsu, Awoniyi Olumide Awonuga, Husam M. Abu‐Soud · 2024 · Molecular and Cellular Biochemistry
39. Phosphatidylinositol 3-kinase p85 regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome
    Jinju Kim, Y. M. Choi, Min A. Hong, Seung-Sik Hwang, Sang Ho Yoon, Soo Jin Chae, Byung Chul Jee, Seung‐Yup Ku, J. G. Kim, S.Y. Moon · 2009 · Human Reproduction
40. Effects of simvastatin pretreatment on clomiphene response in clomiphene - resistant women with polycystic ovary syndrome.
    Azam Azargoon, Raheb Ghorbani, Zahra Faraji · 2013 · Europe PMC (PubMed Central)
41. The link between polycystic ovarian syndrome and type 2 diabetes: preventive and therapeutic approach in Israel.
    Daniela J. Jakubowicz, Julio Wainstein, Roy Homburg · 2012 · PubMed
42. The association between pre-pregnancy impaired fasting glucose and adverse perinatal outcome
    Lina Salman, Nissim Arbib, Anat Shmueli, Eyal Krispin, Arnon Wiznitzer, Eran Hadar · 2018 · Diabetes Research and Clinical Practice
43. Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome
    Maria Mitkova Orbetzova · 2020 · IntechOpen eBooks
44. Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome
    Mira Aubuchon, Jennifer A. Bickhaus, Frank González · 2013 · Springer eBooks
45. Polycystic Ovary Syndrome
    Romana Dmitrović, Richard S. Legro · 2007 · Humana Press eBooks
46. Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects
    K Rautio · 2006
47. Insulin Resistance and Bone Metabolism Markers in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study on Females from the Islamic University Medical Center
    Fahad Khalid Aldhafiri, Fathy Elsayed Abdelgawad, Gihan Mohamed Mohamed Bakri, Tamer Saber · 2023 · Medicina
48. Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies
    Samantha Celeste Garcia-Hernandez, Leonardo M. Porchia, Blanca T. Pacheco-Soto, Esther López‐Bayghen, M. Elba González-Mejía · 2021 · Gynecological Endocrinology
49. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
    Sylvain Bellanger, Marie‐Claude Battista, Jean‐Patrice Baillargeon · 2013 · Springer eBooks
50. Endocrine and Metabolic Effects of Insulin Sensitizers in the Treatment of Patients with Polycystic Ovary Syndrome and Hyperinsulinaemia
    Lilliana Ciotta, Vincenzo De Leo, M. Farina, C Pafumi, Antonio La Marca, Antonio Cianci · 2001 · Gynecologic and Obstetric Investigation
51. Peripubertal Hyperinsulinemia Upregulates Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Ovaries
    Shilla Chakrabarty, Manubai Nagamani · 2008 · Reproductive Sciences
52. CONTROVERSIES IN ENDOCRINOLOGY : A MODERN MEDICAL QUANDARY: POLYCYSTIC OVARY SYNDROME, INSULIN RESISTANCE AND ORAL CONTRACEPTIVE PILLS
    Evanthia Diamanti‐Kandarakis, Jean‐Patrice Baillargeon, M J Jurno · 2003
53. The 6th Annual World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2009 · Diabetes Care
54. Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome
    Riitta M. Koivunen · 2001
55. Renal resistive index in patients with polycystic ovary syndrome
    Gülsen Tüfekçioğlu, Şakir Özgür Keşkek, Okan Dılek, Cengiz Yılmaz · 2019 · Archives of Endocrinology and Metabolism
56. Distribution of normal and pathological OGTTs among pregnant population and non-pregnant women with PCOS – the cross-sectional study
    Miroslava Gojnić-Dugalić, Katarina Jeremić, Aleksandar Stefanović, Aleksandra Jotić, Nebojsa M. Lalic, Svetlana Vrzić-Petronijević, Milos A. Petronijevic, Tanja J. Milicic, Ljiljana Lukić, Jovana Todorović et al. · 2021 · Medicine
57. The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome
    Ozden Yildirim Akan, Oktay Bilgir · 2022 · Revista da Associação Médica Brasileira
58. Polycystic ovarian syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care
    Adrian Hugh Heald, Mark A. Livingston, David Holland, John C. Robinson, Gabriela YC Moreno, Gemma Donnahey, Christopher J. Duff, Pensée Wu, Anthony A. Fryer · 2017 · International Journal of Clinical Practice
59. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome
    Michelle R. Jones, Scott G. Wilson, Benjamin H. Mullin, Robert Mead, Frank Dudbridge, Gerald Francis Watts, Bronwyn G. A. Stuckey · 2008 · Fertility and Sterility
60. Identification of follistatin as a possible trait-causing gene in polycystic ovary syndrome
    Carmela Asteria · 2000 · European Journal of Endocrinology
61. The Polycystic Ovary Syndrome Pathogenesis, Metabolic Implications, and Therapeutic Approach
    Evanthia Diamanti‐Kandarakis · 1997 · Annals of the New York Academy of Sciences
62. Síndrome de ovario poliquístico. Fisiopatología en mujeres obesas y no obesas
    Carlos Vivas, Paola Castaño Trujillo, Gabriel García Trujillo, Martha Liliana Ospina Gutiérrez · 2011 · Redalyc (Universidad Autónoma del Estado de México)
63. Investigation of the relationship between insulin resistance and neuropeptide Y levels in polycystic ovary syndrome
    Tolga Köşeci, Ömer Kaya, Veysel Haksöyler, Didem Derici Yıldırım, Kerem Sezer · 2018 · Marmara medical journal
64. Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?
    Mojca Jensterle, Nika Aleksandra Kravos, Vita Dolžan, Katja Goričar, Rok Herman, Manfredi Rizzo, Andrej Janež · 2021 · Endocrine
65. Genome-Wide Transcriptome Analysis in Type 2 Diabetes Patients Treated by Sitagliptin
    Rui Ma, Xiao-long Deng, Qi-qi-ge Aleteng, Lei Li, Jun Zhu · 2022 · Diabetes Metabolic Syndrome and Obesity
66. The Efficacy of Metformin Treatment on Insulin Resistance and Hyperandrogenism in Lean Women with Polycystic Ovary Syndrome: A Literature Review
    Regis Gu, Nyla Syed · 2023 · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal
67. Biochemistry and Genetics of Human P450c17
    Walter L. Miller, Richard Joseph Auchus · 2000 · KARGER eBooks
68. Insulin resistance in polycystic ovary syndrome: maker or marker?
    Gürkan Bozdağ, Bülent Okan Yıldız · 2009 · Expert Review of Obstetrics & Gynecology
69. Polycystic Ovary Syndrome and Hyperandrogenic States
    R. Jeffrey Chang · 2009 · Elsevier eBooks
70. Wedge resection to improve insulin resistance in polycystic ovary syndrome: a study among Chinese women
    Xiaoke Wu, Yan-Hua Su, Zu‐xuan Zhang · 1996 · BJOG An International Journal of Obstetrics & Gynaecology
71. Adipocyte insulin action in hypogonadotrophic hypogonadism
    Philippa J. Marsden · 2000 · Human Reproduction
72. Oxygen Hyperbaric Exposure Induces GLUT4 Expression Reduction and No Folliculogenesis Alterations in Rat PCOS with Insulin Resistance Model
    Varianida Veterini, Budi Iman Santoso, Widjiati Widjiati · 2015 · Majalah Obstetri & Ginekologi
73. An Update on the Genetics of Polycystic Ovary Syndrome
    Priyal Sharma, Manish Jain, Manish Kumar Tripathi, Mona Sharma, Ashutosh Halder · 2024 · Journal of Endocrinology & Reproduction
74. STUDY OF ADOLESCENT GIRLS WITH MENSTRUALIRREGULARITIES FOR POLYCYSTIC OVARIES AND INSULIN RESISTANCE
    Simi Kumari, Sangeeta Pankaj, Kavita Kavita, Vijayanand Choudhary, Kumar H. Raghwendra · 2015 · Journal of Evolution of Medical and Dental Sciences
75. Ovarian activity before and after gonadal suppression by GnRH-a in patients with polycystic ovary syndrome, hyperandrogenism, hyperinsulinism and acanthosis nigricans
    E.L.A. Motta, Edmund Chada Baracat, Mauro Abi Haidar, I. Juliano, G. Rodrigues de Lima · 1998 · Revista da Associação Médica Brasileira
76. Molecular investigation of genetic factors associated with insulin resistance and obesity in a South African population
    Zelda Vergotine · 2015 · SUNScholar (Stellenbosch University)
77. Exploring the Role of Kisspeptin in Polycystic Ovary Syndrome and Its Associated Pregnancy Complications
    Shaohua Zhang, Xinmeng Sun, Haiyun Guan, Rongmin Wang, Wei Zhang, Hexia Xia · 2025 · Obesity Reviews
78. Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray
    Ziqian Sun, Yang Wang, Tianshu Wei, Li Liu · 2022 · BMC Medical Genomics
79. Polycystic Ovary Syndrome: From Contraception to Hormone Replacement Therapy
    Andrea Riccardo Genazzani, Alessandro David Genazzani · 2014 · ISGE series
80. Polycystic Ovary Syndrome and Its Metabolic Complications
    Emilia Pauline Liao, Leonid Poretsky · 2006 · Humana Press eBooks
81. Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome
    Prathima Jasti, Andrea Elizabeth Dunaif · 2012 · Endocrinology and Metabolism
82. Pathogenesis of PCOS: From Metabolic and Neuroendocrine Implications to the Choice of the Therapeutic Strategy
    Alessia Prati, Andrea R. Genazzani, Alessandro David Genazzani · 2021 · ISGE series
83. Metabolic syndrome in patients with the polycystic ovary syndrome
    Dimitrios Panidis, Κωνσταντίνος Τζιόμαλος, Efstathios P. Papadakis · 2013 · Expert Review of Endocrinology & Metabolism
84. The effects of somatostatin in the polycystic ovary syndrome
    DONATELLA DE FUSCO L. FALSE BARBARA ROSINA · 1997 · Journal of Obstetrics and Gynaecology
85. The potential effects of magnesium, chromium, vitamin C, and metformin on inflammatory, hormonal, and metabolic factors of women with polycystic ovary syndrome (PCOS)
    Khadijeh Pouraghajan, Masoomeh Mohamadpour · 2023 · Research Square
86. Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in pcos patients
    Vincenzo De Leo, А. Ла Марка, В. Каппеллі · 2019 · Reproductive Endocrinology
87. Inositol With Metformin Versus Metformin Monotherapy in Polycystic Ovary Syndrome: A Meta‐Analysis of Randomised Controlled Trials
    Milene Vitória Sampaio Sobral, Victor Gonçalves Soares, Hilária Saugo Faria, Lucas Cael Azevedo Ramos Bendaham, Barbara Bombassaro Masiero, Ocílio de Deus da Rocha Ribeiro Gonçalves, Fernando Augusto Barreiros, Marina Ayabe Gomes de Moraes · 2025 · Reproductive Female and Child Health
88. Pharmacotherapeutic importance of phytoconstituents in the management of Polycystic Ovary Syndrome (PCOS) and associated complications
    Varsha Chaudhary, Prakash Haloi, Kavita Munjal, Havagiray R. Chitme · 2025 · Egyptian Journal of Basic and Applied Sciences
89. Adolescent polycystic ovary syndrome: pathophysiology and implications of the disease
    Sajal Gupta, Dinah K. Chen, Anjali Chandra, Lauren Metterle, Shubhangi Kesavan, Ashok Kumar Agarwal · 2009
90. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
    Anne‐Marie Carreau, Marie‐Claude Battista, Jean‐Patrice Baillargeon · 2022 · Springer eBooks
91. Efficacy of Cabergoline Combined with Letrozole Versus Letrozole Alone in Anovulatory Pco Women with Europrolactinaemia, Randomized Controlled Trial
    Mervat Mohamed Harira · 2025 · Evidence Based Women s Health Journal
92. The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
    Susmeeta T. Sharma, John E. Nestler · 2009 · Springer eBooks
93. Adiponectin and Ghrelin Polymorphism in Korean Women with Polycystic Ovary Syndrome
    Hyejin Lee, Eun Kyung Byun, Hwi Ra Park, Jee Young Oh, Young-Sun Hong, Yeon‐Ah Sung, Hyewon Chung · 2006 · Journal of Korean Endocrine Society
94. Differentiation of polycystic ovary syndrome-derived human embryonic stem cells into adipocytes and their glucose consumption
    Jing Li, Fang Wang, Huijuan Kong, Weiwei Liu, Yingpu Sun · 2012 · Gynecological Endocrinology
95. Polycystic ovarian syndrome: Social situation influences outcome
    Mark A. Livingston, David Holland, Anura Kalansooriya, Gabriela YC Moreno, Gemma Donnahey, Christopher J. Duff, Pensée Wu, Anthony A. Fryer, Adrian Hugh Heald · 2017 · International Journal of Clinical Practice
96. Study of prevalence of insulin resistance and other metabolic abnormalities in various phenotypes of polycystic ovary syndrome in central India
    Deepti Gupta, R. C. Upadhyaya, ANJLINA BHATI · 2020 · International Journal of Reproduction Contraception Obstetrics and Gynecology
97. Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause
    Alessandro David Genazzani, Fedora Ambrosetti, Giulia Despini, Manzo Alba, Martina Caroli, Melania Arnesano, Tabatha Petrillo, Tomatis Veronica, Andrea Ricardo Genazzani · 2021 · ISGE series
98. Conceptos básicos sobre infertilidad, incluido el síndrome de poliquistosis ovárica
    Maryse Brassard, Youssef Ainmelk, Jean‐Patrice Baillargeon · 2008 · Clínicas médicas de Norteamérica
99. THE GENETICS OF INSULIN RESISTANCE IN FAMILIES WITH POLYCYSTIC OVARY SYNDROME
    Jocelyn Matar · 2006 · D-Scholarship@Pitt (University of Pittsburgh)
100. A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
     Dan Grisaru, Foad Azem, Meirav Oren, A. Baram, Michal Inbar, Joseph B. Lessing · 1996 · Gynecological Endocrinology